A 96‐week, multinational, randomized, double‐blind, parallel‐group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes

Yuan‐Di C. Halvorsen; Geoffrey A. Walford; Joseph Massaro; Robert P. Aftring; Mason W. Freeman

doi:10.1111/dom.13833

A 96‐week, multinational, randomized, double‐blind, parallel‐group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13833 ◽

2019 ◽

Vol 21 (11) ◽

pp. 2496-2504 ◽

Cited By ~ 3

Author(s):

Yuan‐Di C. Halvorsen ◽

Geoffrey A. Walford ◽

Joseph Massaro ◽

Robert P. Aftring ◽

Mason W. Freeman

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Decision letter for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Review for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v2/review1 ◽

2019 ◽

Author(s):

Kyu Yong Cho

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Decision letter for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v2/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double‐blind, active‐controlled, parallel group, multinational clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12399 ◽

2014 ◽

Vol 17 (2) ◽

pp. 136-144 ◽

Cited By ~ 18

Author(s):

S. A. Ross ◽

A. E. Caballero ◽

S. Del Prato ◽

B. Gallwitz ◽

D. Lewis‐D'Agostino ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Newly Diagnosed ◽

Double Blind ◽

Parallel Group ◽

Multinational Clinical Trial ◽

Initial Combination

Download Full-text

Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12435 ◽

2015 ◽

Vol 17 (6) ◽

pp. 599-602 ◽

Cited By ~ 23

Author(s):

S.‐M. Jin ◽

C.‐Y. Park ◽

Y. M. Cho ◽

B. J. Ku ◽

C. W. Ahn ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Parallel Group

Download Full-text

Review for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v2/review2 ◽

2019 ◽

Author(s):

Afshin Salsali

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Author response for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v2/response1 ◽

2019 ◽

Author(s):

Yuan‐Di Halvorsen ◽

Geoffrey A Walford ◽

Joseph Massaro ◽

R. Paul Aftring ◽

Mason W. Freeman

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Author Response ◽

Double Blind ◽

Parallel Group

Download Full-text

Review for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v1/review2 ◽

2019 ◽

Author(s):

Kyu Yong Cho

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

Review for "A 96‐Week Multinational Randomized Double‐Blind Parallel‐Group Clinical Trial Evaluating the Safety and Effectiveness of Bexagliflozin as a Monotherapy for Adults with Type 2 Diabetes"

10.1111/dom.13833/v1/review1 ◽

2019 ◽

Author(s):

Afshin Salsali

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Double Blind ◽

Parallel Group

Download Full-text

P2366 Atorvastatin in patients with type 2 diabetes on haemodialysis: design and patient characteristics of a double-blind clinical trial (die deutsche diabetes dialyse study)

European Heart Journal ◽

10.1016/s0195-668x(03)95360-7 ◽

2003 ◽

Vol 24 (5) ◽

pp. 461

Author(s):

W MARZ

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Patient Characteristics ◽

Double Blind ◽

Double Blind Clinical Trial

Download Full-text